Frequently Asked Questions
Common Questions About Using ICD-10 Code G72.41 for Inclusion body myositis [IBM]
What are the common symptoms of Inclusion body myositis?
Common symptoms include progressive muscle weakness, particularly in the arms and legs, difficulty with fine motor tasks, and muscle atrophy. Patients may also experience fatigue and occasional muscle cramps.
How is Inclusion body myositis diagnosed?
Diagnosis typically involves a combination of clinical evaluation, muscle strength testing, and muscle biopsy, which reveals characteristic inclusion bodies. Blood tests may also be performed to rule out other conditions.
Is Inclusion body myositis a contagious condition?
No, Inclusion body myositis is not contagious. It is an autoimmune condition that affects muscle tissue and is not transmitted from person to person.
What treatment options are available for Inclusion body myositis?
Treatment focuses on managing symptoms and may include physical therapy, occupational therapy, and nutritional support. Corticosteroids may be considered in some cases to reduce inflammation.
